Connection

WOLFGANG WINKELMAYER to Myocardial Infarction

This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Myocardial Infarction.
Connection Strength

3.913
  1. Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis. Nephrol Dial Transplant. 2018 09 01; 33(9):1590-1597.
    View in: PubMed
    Score: 0.363
  2. Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease. Kidney Int. 2016 08; 90(2):411-421.
    View in: PubMed
    Score: 0.310
  3. Sleep disordered breathing and cardiovascular risk in older patients initiating dialysis in the United States: a retrospective observational study using medicare data. BMC Nephrol. 2016 Feb 09; 17:16.
    View in: PubMed
    Score: 0.304
  4. Warfarin treatment in patients with atrial fibrillation and advanced chronic kidney disease: sins of omission or commission? JAMA. 2014 Mar 05; 311(9):913-5.
    View in: PubMed
    Score: 0.266
  5. Kidney function and long-term medication adherence after myocardial infarction in the elderly. Clin J Am Soc Nephrol. 2011 Apr; 6(4):864-9.
    View in: PubMed
    Score: 0.214
  6. Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy. Arch Intern Med. 2008 Nov 24; 168(21):2368-75.
    View in: PubMed
    Score: 0.184
  7. Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol. 2008 Sep; 3(5):1415-22.
    View in: PubMed
    Score: 0.179
  8. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008 Apr 01; 51(13):1247-54.
    View in: PubMed
    Score: 0.176
  9. Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age. Am J Cardiol. 2008 Jun 01; 101(11):1531-6.
    View in: PubMed
    Score: 0.176
  10. Medication adherence after myocardial infarction: a long way left to go. J Gen Intern Med. 2008 Feb; 23(2):216-8.
    View in: PubMed
    Score: 0.174
  11. Use of recommended medications after myocardial infarction in Austria. Eur J Epidemiol. 2008; 23(2):153-62.
    View in: PubMed
    Score: 0.172
  12. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Am J Cardiol. 2007 Oct 01; 100(7):1061-7.
    View in: PubMed
    Score: 0.168
  13. Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease. Kidney Int. 2007 May; 71(9):938-45.
    View in: PubMed
    Score: 0.164
  14. Angiotensin inhibition after myocardial infarction: does drug class matter? J Gen Intern Med. 2006 Dec; 21(12):1242-7.
    View in: PubMed
    Score: 0.161
  15. Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol. 2006 Jul; 1(4):796-801.
    View in: PubMed
    Score: 0.155
  16. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. Am J Kidney Dis. 2006 Feb; 47(2):301-8.
    View in: PubMed
    Score: 0.152
  17. Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group. Kidney Int. 2023 06; 103(6):1028-1037.
    View in: PubMed
    Score: 0.125
  18. Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis. Eur Heart J. 2019 03 14; 40(11):887-898.
    View in: PubMed
    Score: 0.094
  19. Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. Nephrol Dial Transplant. 2015 Dec; 30(12):2068-75.
    View in: PubMed
    Score: 0.074
  20. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. Am J Kidney Dis. 2015 Jul; 66(1):106-13.
    View in: PubMed
    Score: 0.072
  21. Use and safety of heparin-free maintenance hemodialysis in the USA. Nephrol Dial Transplant. 2013 Jun; 28(6):1589-602.
    View in: PubMed
    Score: 0.062
  22. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf. 2008 Dec; 17(12):1189-96.
    View in: PubMed
    Score: 0.046
  23. Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis. 2005 Aug; 46(2):225-32.
    View in: PubMed
    Score: 0.037
  24. Drug-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Kidney Transplant Recipients. Transplantation. 2017 Apr; 101(4):851-857.
    View in: PubMed
    Score: 0.021
  25. Detecting clinically meaningful biomarkers with repeated measurements: An illustration with electronic health records. Biometrics. 2015 Jun; 71(2):478-86.
    View in: PubMed
    Score: 0.018
  26. Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes. 2014 Jan; 7(1):157-62.
    View in: PubMed
    Score: 0.016
  27. Coronary artery bypass graft type and outcomes in maintenance dialysis. J Cardiovasc Surg (Torino). 2015 Jun; 56(3):463-71.
    View in: PubMed
    Score: 0.016
  28. Multivessel coronary revascularization and outcomes in kidney transplant recipients. Transpl Int. 2013 Nov; 26(11):1080-7.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.